NATIXIS ADVISORS, L.P. – Regeneron Pharmaceuticals, Inc. Transaction History
NATIXIS ADVISORS, L.P. portfolio value:
$92.90M
portfolio value
NATIXIS ADVISORS, L.P. quarter portfolio value change:
+16.53%
quarter
Regeneron Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -0.24% | -326 shares | 12.98M | $688.87 | 134.86K |
| Q2 2022 | share | Decrease | -23.14% | -40.70K shares | -42.93M | $591.13 | 135.19K |
| Q1 2022 | share | Decrease | -2.98% | -5.39K shares | 8.35M | $698.42 | 175.89K |
| Q4 2021 | share | Decrease | -28.30% | -71.56K shares | -38.53M | $642.51 | 181.29K |
| Q3 2021 | share | Increase | +84.39% | 115.72K shares | 76.42M | $605.18 | 252.85K |
| Q2 2021 | share | Decrease | -0.87% | -1.20K shares | 11.14M | $558.54 | 137.13K |
| Q1 2021 | share | Decrease | -3.54% | -5.07K shares | -3.83M | $473.14 | 138.33K |
| Q4 2020 | share | Decrease | -23.12% | -43.12K shares | -35.13M | $483.11 | 143.41K |
| Q3 2020 | share | Decrease | -4.10% | -7.97K shares | -16.88M | $559.78 | 186.53K |
| Q2 2020 | share | Decrease | -7.06% | -14.78K shares | 19.10M | $623.65 | 194.50K |
| Q1 2020 | share | Increase | +0.30% | 624 shares | 23.84M | $488.29 | 209.29K |
| Q4 2019 | share | Decrease | -0.82% | -1.72K shares | 19.98M | $375.48 | 208.67K |
| Q3 2019 | share | Increase | +1.70% | 3.52K shares | -6.38M | $277.4 | 210.39K |
| Q2 2019 | share | Increase | +0.23% | 471 shares | -20.00M | $313 | 206.86K |
| Q1 2019 | share | Increase | +3.67% | 7.30K shares | 10.39M | $410.62 | 206.39K |
| Q4 2018 | share | Decrease | -3.47% | -7.16K shares | -8.97M | $373.5 | 199.08K |
| Q3 2018 | share | Increase | +8.88% | 16.82K shares | 17.98M | $404.04 | 206.25K |
| Q2 2018 | share | Increase | +5.96% | 10.64K shares | 3.78M | $344.99 | 189.42K |
| Q1 2018 | share | Increase | 0.00% | 178.77K shares | 61.56M | $344.36 | 178.77K |
| Q4 2017 | share | Increase | +3.23% | 4.13K shares | -7.55M | $375.96 | 132.16K |
| Q3 2017 | share | Decrease | -3.73% | -4.96K shares | -8.07M | $447.12 | 128.03K |
| Q2 2017 | share | Increase | +2.92% | 3.77K shares | 15.24M | $491.14 | 132.99K |
| Q1 2017 | share | Increase | +22.03% | 23.32K shares | 11.20M | $387.51 | 129.22K |
| Q4 2016 | share | Increase | +50.38% | 35.47K shares | 10.56M | $367.09 | 105.89K |
| Q3 2016 | share | Increase | 0.00% | 70.41K shares | 28.30M | $402.02 | 70.41K |